Sentence examples for expectancy and cost from inspiring English sources

Life expectancy and cost are discounted at 3% per year [18].

We used a computer-based simulation model of HIV detection and treatment [7], [8], [11], [12] to estimate the changes in life expectancy, quality-adjusted life expectancy, and cost associated with a population-wide program of routine HIV screening once, every five years, and annually in adults aged 18 69.

The mean life expectancy and costs for each of the 12 subgroups of TB and HIV patients were weighted by the frequency of their occurrence to determine the overall projected mean life expectancy and cost for each HIV testing referral strategy (Tables S2, S3, S4).

Wallace et al. have compared the effectiveness of different strategies for the pre-operative assessment, including life expectancy and cost effectiveness.

Quetiapine (IR or XR) in combination with lithium or divalproex is also associated with quality-adjusted life expectancy and cost-effectiveness benefits relative to maintenance treatment with mood stabilizers alone (Plosker [2012]).

On the other hand, generic models addressing broad clinical questions that can be adapted from one patient to another, can often make valid projections about specific outcomes, such as life expectancy, quality-adjusted life expectancy, and cost-effectiveness issues, and represent a useful approach to clinical decision making.

Outcome measures were assessed from a modified societal perspective and life expectancy, quality-adjusted life expectancy, and costs (2007 €) were discounted at a rate of 3% per annum [14].

First, we take an individual perspective, and consider the differences in remaining life expectancy and costs of health services use over remaining lifetime at 65 in 2050.

Using second-order Monte Carlo simulation, Type 2 diabetes progression was simulated in 1000 patients through the model 1000 times to calculate the mean and standard deviation of life expectancy, quality-adjusted life expectancy, and costs [ 12].

For automated DNA ploidy analysis to be considered as an alternative for the screening of cervical malignancies, an evaluation with regard to both quality-adjusted life expectancy and costs is needed.

This result is common in cost of illness studies in other areas of treatment, as incidence-based approaches have more stringent requirements regarding the information needed to carry out the analysis; indeed, incidence-based studies require life-expectancy and cost estimates incurred throughout the natural course of the disease.